On a positive front we have yet another pharmaceutical company announce promising developments in their own vaccine trials.
For the second time this month, there's promising news from a COVID-19 vaccine candidate. Moderna said Monday its shots provide strong protection, a dash of hope against the grim backdrop of coronavirus surges in the U.S. and around the world.
Moderna said its vaccine is 94.5% effective, according to preliminary data from the company's ongoing study. A week ago, competitor Pfizer announced its own COVID-19 vaccine appeared similarly effective — news that puts both companies on track to seek permission within weeks for emergency use in the U.S.
Dr. Stephen Hoge, Moderna's president, welcomed the "really important milestone" but said having similar results from two different companies is what's most reassuring.
CBS, Nov. 16, 2020
Finally, some light at the end of our dark pandemic tunnel.
On another note, I remain confused by testing for COVID-19. On the news this morning there was discussion on a number of things in connection with testing including the prediction of a shortfall in resources, and the limited benefit of it. One person was tested four times by the same nurse with varying results. Another, who already had the virus, received a 'false positive.' I don't discount the need for testing, but see its limitations. I'm concerned, especially with the holidays coming up, that people will rush to be tested, receive a negative result, assume they are safe, let their guard down, and later discover they got a false negative. We must use testing as one tool among many, but recognize its limitations.